Dissanayake, S.K., Olkhanud, P.B., O’Connell, M.P., Carter, A., French, A.D., Camilli, T.C., et al. (2008) Wnt5A Regulates Expression of Tumor-Associated Antigens in Melanoma via Changes in Signal Transducers and Activators of Transcription 3 Phosphorylation. Cancer Research, 68, 10205-10214.

has been cited by the following article:

• TITLE: Cystatin C Peptide Effects on B16F10 Melanoma Cells

  AUTHORS: Mathieu Hill, James L. Cox

  KEYWORDS: Cystatin, Peptide, Melanoma, Metastasis

  JOURNAL NAME: CellBio, Vol.10 No.1, March 17, 2021

  ABSTRACT: Background: Metastasis is a major problem for effective therapy of cancer. Small cysteine protease inhibitors, cystatins have been shown to be anti-metastatic for a number of different cancers. We have identified a small peptide of cystatin which exhibits anti-cancer properties for B16 melanoma cells in vitro. Methods: B16 melanoma cells were measured for growth, proliferation, migration, and apoptosis in the presence and absence of cystatin peptide. Results: The cystatin peptide reduced melanoma cell growth, proliferation, migration, and increased apoptosis in melanoma cells in culture. Conclusion: Cystatin peptide exhibits anti-cancer effects on highly metastatic B16 melanoma cells in culture.